These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20590574)

  • 1. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
    Jamontt JM; Molleman A; Pertwee RG; Parsons ME
    Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of O-1602 and CBD on TNBS-induced colonic disturbances.
    Wei D; Wang H; Yang J; Dai Z; Yang R; Meng S; Li Y; Lin X
    Neurogastroenterol Motil; 2020 Mar; 32(3):e13756. PubMed ID: 31802588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
    Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
    Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
    Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.
    Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP
    Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis.
    Becker W; Alrafas HR; Busbee PB; Walla MD; Wilson K; Miranda K; Cai G; Putluri V; Putluri N; Nagarkatti M; Nagarkatti PS
    J Crohns Colitis; 2021 Jun; 15(6):1032-1048. PubMed ID: 33331878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol modulation of antinociceptive tolerance to Δ
    Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
    Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
    Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
    Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
    Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
    Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
    Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
    Britch SC; Craft RM
    J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
    Brady KT; Balster RL
    Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cannabidiolic acid and ∆
    Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
    Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.